F
Frensenius Vascular Care
Fresenius Vascular Care develops and manages specialty outpatient vascular centers that deliver vascular care services.
About Frensenius Vascular Care
Fresenius Vascular Care, operating under the Azura Vascular Care brand, specializes in providing expert vascular care services. The company focuses on enhancing dialysis access and managing various vascular conditions, serving patients who require specialized vascular interventions. Operating in the healthcare sector, Fresenius Vascular Care primarily caters to patients with chronic kidney disease who need dialysis, as well as individuals with other vascular health issues. The business model revolves around outpatient care centers where patients receive treatments such as angioplasty, vascular access ultrasounds, and management of dialysis access complications. Revenue is generated through patient services, insurance reimbursements, and partnerships with healthcare providers. The company has expanded its reach across multiple states, including Florida and Alabama, ensuring accessibility to high-quality vascular care.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2005
- Headquarters
- Upper Merion Township, United States
- Employees
- 113
- Open positions
- None listed
- Dealroom signal
- 28.7/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Testing, Risk Management, Biotechnology, Patient Care, Non-Invasive medical devices and treatments, Biotech and Pharma, Hard Tech, medical testing, DT and LS, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCOther financing | Oct 2023 | $6.9M | $44M | Undisclosed | ↗ |
| EARLY VCOther financing | May 2023 | $740K | $44M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Frensenius Vascular Care is 250 monthly website visits, up 13.6% over the last three months. Frensenius Vascular Care's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Frensenius Vascular Care on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Frensenius Vascular Care’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.